Showing results (181-190 of 246) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2025
Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activityAdam J Fountain, Natalie J E Waller, Chen-Yi Cheung, et al.
Advances in Microbial Physiology|September 27, 2022
Antimicrobial tolerance and its role in the development of resistance: Lessons from enterococciRachel L Darnell, Olivia Paxie, Francesca O Todd Rose, et al.
Journal of Natural Products|February 29, 2024
Synthesis, Structure-Activity Relationship Study, Bioactivity, and Nephrotoxicity Evaluation of the Proposed Structure of the Cyclic Lipodepsipeptide Brevicidine BDennise Palpal-Latoc, Aimee J Horsfall, Alan J Cameron, et al.
Emerging Infectious Diseases|October 21, 2021
Genomic Profiling of Mycobacterium tuberculosis Strains, MyanmarHtin Lin Aung, Wint Wint Nyunt, Yang Fong, et al.
Antimicrobial Agents and Chemotherapy|July 19, 2021
Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine, and Linezolid in a Murine Model of TuberculosisWei Yu, Buhari Yusuf, Shuai Wang, et al.
ACS Infectious Diseases|February 25, 2020
Antituberculosis Activity of the Antimalaria Cytochrome bcc Oxidase Inhibitor SCR0911Shi Min Sherilyn Chong, Malathy Sony Subramanian Manimekalai, Jickky Palmae Sarathy, et al.
Frontiers in Chemistry|August 23, 2021
A Concise Synthetic Strategy Towards the Novel Calcium-dependent Lipopeptide Antibiotic, Malacidin A and AnaloguesNadiia Kovalenko, Georgina K Howard, Jonathan A Swain, et al.
Chemmedchem|September 9, 2024
Phenotypic-Based Discovery and Exploration of a Resorufin Scaffold with Activity against Mycobacterium tuberculosisEric Tran, Chen-Yi Cheung, Lucy Li, et al.
Chemical Science|June 7, 2021
"CLipP"ing on lipids to generate antibacterial lipopeptidesVictor Yim, Iman Kavianinia, Melanie K Knottenbelt, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2025
Prolonged exposure to teixobactin generates cross-tolerance to other cell wall-targeting antimicrobials in Enterococcus faecalisRachel L Darnell, Melanie K Knottenbelt, Olivia E Rose, et al.
Pageof 25